Beigene Ltd Share Price Hong Kong S.E.
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- HKD | - |
Sales 2024 * | 3.22B 25.15B 253B | Sales 2025 * | 4.02B 31.38B 315B | Capitalization | 15.97B 125B 1,252B |
---|---|---|---|---|---|
Net income 2024 * | -862M -6.73B -67.57B | Net income 2025 * | -346M -2.7B -27.12B | EV / Sales 2024 * | 4.47 x |
Net cash position 2024 * | 1.59B 12.38B 124B | Net cash position 2025 * | 1.02B 7.97B 80.02B | EV / Sales 2025 * | 3.72 x |
P/E ratio 2024 * |
-16.9
x | P/E ratio 2025 * |
-39.2
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.21% |
Latest transcript on Beigene Ltd
1st Jan change | Capi. | |
---|---|---|
+12.30% | 118B | |
+12.15% | 106B | |
-8.14% | 23.4B | |
+0.12% | 21.78B | |
-9.12% | 18.09B | |
-41.25% | 16.72B | |
+5.80% | 14.03B | |
+28.03% | 11.67B | |
-31.18% | 7.55B |